Combined MEK and JAK/STAT3 pathway inhibition effectively decreases medulloblastoma tumor progression.
Ontology highlight
ABSTRACT: Combined MEK and JAK/STAT3 pathway inhibition effectively decreases medulloblastoma tumor progression.
PROVIDER: PRJNA698708 | ENA |
REPOSITORIES: ENA
ACCESS DATA